Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Investigation|July 15, 1997
Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brainP Gressens, S Marret, J M Hill, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 17, 2008
The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crushT Jehle, C Dimitriu, S Auer, et al.
Annals of the New York Academy of Sciences|February 17, 2000
Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factorJ M Hill, G W Glazner, S J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1993
A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growthT W Moody, F Zia, M Draoui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 1996
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptideI Gozes, A Bardea, A Reshef, et al.
Brain Research. Developmental Brain Research|April 18, 1997
Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificityI Gozes, A Davidson, Y Gozes, et al.
Pediatric Nephrology (Berlin, Germany)|January 10, 2001
Experimental intrauterine growth retardation alters renal developmentH Bassan, L L Trejo, N Kariv, et al.
Life Sciences|February 12, 2000
(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell linesH Zia, J Leyton, M Casibang, et al.
Pageof 18